Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000237430

Medchemexpress LLC (E)-2-(((5-bromothiophen-2-yl)methylene)amino)benzamide | 304456-62-0 | 98.0% | 309.18 | C12H9BrN2OS | 5MG
SDP

Supplier:  Medchemexpress LLC HY1244475MG

Encompass_Preferred

BTYNB is a small-molecule research inhibitor of IMP1 (IGF2BP1) that disrupts IMP1 binding to c-Myc mRNA, resulting in reduced c-Myc expression and decreased proliferation in IMP1-positive cancer cell lines. The compound is supplied as a solid reagent in multiple sizes and as a 10 mM solution in DMSO for convenient stock preparation, and is reported with high purity for in vitro applications.

  • Inhibits IMP1 binding to c-Myc mRNA with reported IC50 ≈ 5 μM.
  • High reported purity suitable for in vitro research applications.
  • Available in multiple solid pack sizes and a 10 mM solution format in DMSO.
  • Soluble in DMSO for preparation of concentrated stock solutions.
  • Used to study RNA-protein interactions and cancer cell proliferation.

Catalog No. 50-002-37430


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.